Literature DB >> 2908827

B16 melanoma spontaneous brain metastasis: occurrence and development within leptomeninges blood vessels.

A L Alterman1, C W Stackpole.   

Abstract

Subcutaneous tumors initiated with mouse B16 melanoma clones G3.5 and G3.12 disseminated visible spontaneous brain metastases in 67 per cent and 32 per cent, respectively, of mice with extensive lung metastasis. Most brain metastases appeared as pigmented emboli within blood vessels of the leptomeninges overlying the cerebral cortex. Intravascular metastases consisted of tumor cell aggregates surrounded by fibrous material and generally contained viable cells that proliferated in culture. Some metastatic emboli apparently proliferated intravascularly to such an extent as to cause vessel disruption, permitting tumor invasion into the adjacent cerebral cortex. Cultured cells from G3.12 leptomenings metastases produced tumors that metastasized to a much greater extent than unselected G3.12 tumors, but brain metastasis still occurred only secondarily, after initial dissemination to the lungs. In contrast, G3.5 brain metastasis-derived populations formed tumors that ultimately metastasized to the brain to lesser extents than did unselected G3.5 tumors. One selected variant, G3.12/BM2, reproducibly formed visible and viable brain metastases in more than 80 per cent of tumor-bearing mice, and lethal or potentially lethal brain metastases in 10-15 per cent of mice. This variant may serve as a model for clinical brain metastasis.

Entities:  

Mesh:

Year:  1989        PMID: 2908827     DOI: 10.1007/BF02057178

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  15 in total

1.  Selection and altered properties of brain-colonising metastatic melanoma.

Authors:  K W Brunson; G Beattie; G L Nicolsin
Journal:  Nature       Date:  1978-04-06       Impact factor: 49.962

2.  Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival.

Authors:  M H Amer; M Al-Sarraf; L H Baker; V K Vaitkevicius
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

3.  Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain meninges-colonizing murine B16 melanoma.

Authors:  K M Miner; T Kawaguchi; G W Uba; G L Nicolson
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

4.  Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients.

Authors:  G A Grooms; F R Eilber; D L Morton
Journal:  J Surg Oncol       Date:  1977       Impact factor: 3.454

5.  Intracranial metastases due to prostatic carcinoma.

Authors:  J E Castaldo; J L Bernat; F A Meier; A R Schned
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

6.  Syngeneic monoclonal antibodies to B16 melanoma viral antigens.

Authors:  I Rappaport; A L Alterman; S Braverman; C W Stackpole
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

7.  Brain metastases in breast cancer patients receiving adjuvant chemotherapy.

Authors:  A H Paterson; M Agarwal; A Lees; J Hanson; O Szafran
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

8.  Brain meninges tumor formation by in vivo-selected metastatic B16 melanoma variants in mice.

Authors:  T Kawaguchi; M Kawaguchi; K M Miner; T M Lembo; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

9.  Murine models of metastatic neoplasia to the central nervous system.

Authors:  F K Conley
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

10.  Murine melanoma: a model for intracranial metastasis.

Authors:  A Raz; I R Hart
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

View more
  6 in total

Review 1.  The biology of brain metastases-translation to new therapies.

Authors:  April F Eichler; Euiheon Chung; David P Kodack; Jay S Loeffler; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2011-04-12       Impact factor: 66.675

2.  Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.

Authors:  Ling-Yuan Kong; Alexander Gelbard; Jun Wei; Chantal Reina-Ortiz; Yongtao Wang; Eric C Yang; Yared Hailemichael; Izabela Fokt; Arumugam Jayakumar; Wei Qiao; Gregory N Fuller; Willem W Overwijk; Waldemar Priebe; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2010-04-13       Impact factor: 12.531

3.  B16 melanoma variants selected by one or more cycles of spontaneous metastasis to the same organ fail to exhibit organ specificity.

Authors:  C W Stackpole; A L Alterman; E F Valle
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

Review 4.  Preclinical approaches to study the biology and treatment of brain metastases.

Authors:  William Cruz-Muñoz; Robert S Kerbel
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

5.  Patterning of B16 melanoma metastasis and colonization generally relates to tumor cell growth-stimulating or growth-inhibiting effects of organs and tissues.

Authors:  E F Valle; A D Zalka; L Groszek; C W Stackpole
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

6.  High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeninges.

Authors:  Arian Lasocki; Chloe Khoo; Peter K H Lau; David L Kok; Grant A Mcarthur
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.